| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.6 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |